Skip to main content
. 2020 Aug 21;11:1992. doi: 10.3389/fmicb.2020.01992

Figure 3.

Figure 3

The RIG-I-like receptors (RLRs) antiviral signaling pathway. After the virus invades the body, RLRs recognizes the viral RNA and interacts with mitochondrial antiviral signaling (MAVS) to activate it. Then, it transduces the signal to the downstream TNF receptor associated factor 2/6 (TRAF2/6) and TRAF3, further activates IκB kinases (IkK complex) and TANK-binding kinases (TBK1) complex and nuclear transcription factor κB (NF-κB) and interferon regulatory factor 3 (IRF3), and induces the expression of various proinflammatory factors and interferon and finally produces an efficient antiviral immune response.